We've been selling-producing! Reproducing the company in response to COVID-19. (Q4418536): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Import item from Poland) |
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
||
| Property / contained in NUTS | |||
| Property / contained in NUTS: Łódzki / rank | |||
Normal rank | |||
Revision as of 23:10, 27 October 2022
Project Q4418536 in Poland
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | We've been selling-producing! Reproducing the company in response to COVID-19. |
Project Q4418536 in Poland |
Statements
884,968.78 zloty
0 references
196,728.56 Euro
0 references
1,041,139.74 zloty
0 references
231,445.36 Euro
0 references
85.0 percent
0 references
1 February 2021
0 references
31 January 2022
0 references
MAGNAPHARMA SP. Z O.O.
0 references
Projekt przewiduje przeprofilowanie firmy Magnapharma z firmy handlowej, na firmę produkcyjno - handlową. Dotychczas firma wnioskodawcy zajmowała się sprzedażą gotowych wyrobów produkowanych według pomysłu firmy Magnapharma, przez firmy posiadające możliwości produkcyjne. Ta działalność wraz z aktywnością badawczo rozwojową skutkuje bogatą możliwością pracy nad produktami i poszerzeniem swojej oferty. Magnapharma jako firma handlowa, oferująca usługi na rynku produktów nie będących tzw. pierwszej potrzeby w ostatnich kilku miesiącach zanotowała drastyczny spadek obrotów. Koszty generowane są szczególnie po stronie wykonania produktu gotowego. W związku z tym uniezależnienie się od kosztownej produkcji zleconej - poprzez przeprofilowanie firmy i jej działalności jest ratunkiem dla Magnapharma sp. z o.o. Firma wnioskuje o środki na uruchomienie linii produkcyjnej własnych produktów dermokosmetyków, środki na wykupienie know how od firmy, której zleca dotychczas produkcję, koszty rejestracji nowych wyrobów, wybudowanie hali produkcyjnej oraz wynagrodzenia dla kadry. Pozwoli to na szybkie uruchomienie produkcji dotychczasowej linii produktów wg znacznie niższych kosztów, oraz wdrożenie nowych według zapotrzebowania rynku. Firma zyska możliwość elastycznego reagowania na trendy i zapotrzebowanie rynkowe. Dodatkowo w przypadku dalszego postępu pandemii będzie mogła wdrożyć produkty z linii wiruso i bakteriobójczej według własnej technologii. Projekt realizowany będzie w dwóch etapach i obejmie: 1. Zadanie 1 – Wyposażenie bazy lokalowej, działania promocyjne, realizacja w terminie 01.10.2020 – 31.01.2021, 2. Zadanie 2 – Rozwój firmy, w tym utrzymanie zatrudnienia i zatrudnienie nowych pracowników, realizacja w terminie 01.02.2021 – 31.12.2021. Projekt realizowany będzie w wynajmowanej hali w Konstantynowie Łódzkim, ul. Boczna 22/24. (Polish)
0 references
The project envisages the refouling of Magnapharma from a trading company to a manufacturing and commercial company. So far, the applicant’s company has been engaged in the sale of finished products manufactured according to the idea of Magnapharma, by companies with production capabilities. This activity, together with R & D activities, results in a rich opportunity to work on products and broaden their offer. Magnapharma, as a trading company offering services on the market of non-essential products, has recorded a drastic decline in turnover in the last few months. The costs are generated especially on the side of the finished product. Therefore, independence from expensive commissioned production — by reproducing the company and its activities is a rescue for Magnapharma sp. z o.o. The company applies for funds to start the production line of its own dermocosmetics products, funds to buy know how from the company to which production has been commissioned, costs of registration of new products, construction of a production hall and remuneration for staff. This will allow for a quick start of production of the existing product line at much lower costs, as well as the implementation of new ones according to market demand. The company will be able to respond flexibly to market trends and demand. In addition, if the pandemic continues, it will be able to deploy virus and bactericidal products according to its own technology. The project will be implemented in two stages and will include: 1. Task 1 — Equipment of the premises, promotional activities, implementation within the deadline 01.10.2020-31.01.2021, 2. Task 2 — Development of the company, including maintenance of employment and employment of new employees, implementation between 01.02.2021 and 31.12.2021. The project will be implemented in the rented hall in Konstantynów Łódzkie, ul. Side 22/24. (English)
21 October 2022
0 references
The project envisages the refouling of Magnapharma from a trading company to a manufacturing and commercial company. So far, the applicant’s company has been engaged in the sale of finished products manufactured according to the idea of Magnapharma, by companies with production capabilities. This activity, together with R & D activities, results in a rich opportunity to work on products and broaden their offer. Magnapharma, as a trading company offering services on the market of non-essential products, has recorded a drastic decline in turnover in the last few months. The costs are generated especially on the side of the finished product. Therefore, independence from expensive commissioned production — by reproducing the company and its activities is a rescue for Magnapharma sp. z o.o. The company applies for funds to start the production line of its own dermocosmetics products, funds to buy know how from the company to which production has been commissioned, costs of registration of new products, construction of a production hall and remuneration for staff. This will allow for a quick start of production of the existing product line at much lower costs, as well as the implementation of new ones according to market demand. The company will be able to respond flexibly to market trends and demand. In addition, if the pandemic continues, it will be able to deploy virus and bactericidal products according to its own technology. The project will be implemented in two stages and will include: 1. Task 1 — Equipment of the premises, promotional activities, implementation within the deadline 01.10.2020-31.01.2021, 2. Task 2 — Development of the company, including maintenance of employment and employment of new employees, implementation between 01.02.2021 and 31.12.2021. The project will be implemented in the rented hall in Konstantynów Łódzkie, ul. Side 22/24. (English)
0 references
WOJ.: ŁÓDZKIE, POW.: pabianicki
0 references
Identifiers
RPLD.02.03.01-10-0700/20
0 references